TNFR2 regulates the transcription of PDL1 via the p65 NF-κB pathway, suggesting that BAR502 by downregulating the expression of TNFR2, might restore immune surveillance of pancreatic cancer cells in PDAC (69). Here, TNFRSF1B is linked to pancreatic neoplasm.